CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sci Off & Head Tech Ops gave up 876 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,061 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sci Off & Head Tech Ops gave up 1,947 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 5,273 shares (to pay taxes)
- DEFR14A Other DEFR14A
- 8-K Event Delisting notice
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 10 of 24 · 464 filings